Todd Shriber

Todd Shriber

InvestorPlace Contributor

Recent Articles

7 Biotech ETFs That Should Remain Healthy

By Todd Shriber, InvestorPlace Contributor

The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.

Hexo Stock Is Almost Worth Buying Now

By Todd Shriber, InvestorPlace Contributor

HEXO stock has a lot of headwinds to deal with, so you should wait for it to come in some more before nibbling at it.

Wait for a Pullback Before Jumping in on Micron Stock

By Todd Shriber, InvestorPlace Contributor

Micron is a leader in the production of dynamic random-access memory, or DRAM, chips as well as NAND semiconductors. DRAM chips are integral components in personal computers while NAND chips are used to produce smartphones, among other tech gadgets. On multiple fronts, Micron stock is sensitive to semiconductor demand trends and those trends are appearing tepid for 2019.

Dow Jones Today: Trade Trouble is a Real Problem

By Todd Shriber, InvestorPlace Contributor

The impact of previous tariffs has been felt in multiple corners of the economy. So much so that data confirm China is no longer the biggest trading partner of the U.S. In a report out today, the Commerce Department said American exports to China slumped 18% in the first half of the year and that China is now the third-largest U.S. trading partner behind Mexico and Canada.

5 Dependable Dividend ETFs to Invest In

By Todd Shriber, InvestorPlace Contributor

With the U.S. remaining one of the dominant forces in global dividend growth and interest rates here declining, investors can mix and match both dividend growth and high dividend ETFs in the current market environment. Here are some of the dividend ETFs that are primed to deliver for investors over the rest of 2019 and beyond.

Load More